Table 4.
Clinical studies on the effects of dietary berry intervention in adults with T2D
Reference (year) | Participants | Study design | Intervention | Significant findings |
---|---|---|---|---|
Schell et al. (2019)83 | Adults with T2D on medications sample size: n = 25 | Randomized, 2- phase crossover study | Phase 1: Postprandial response (4 h) to raspberry supplementation (Tx1); or control meal (Cx1) | ↓2-Hour and 4-hour BG in Tx1 vs. Cx1 |
Phase 2: Raspberry supplementation (Tx2) or controlled diet without raspberries (Cx1) followed by 2-week washout; for 10 weeks | ↓4-Hour IL-6 and hsTNF-α in Tx1 vs. Cx1 ↓IL-6 and hsTNF-α in Tx2 vs. Cx2 |
|||
Lazavi et al. (2018)88 | Adults with T2D on medications sample size: n = 42 | Randomized, controlled, parallel-arm study | Barberry juice 200 mL day−1 (Tx1); or non-intervention group (Cx1) for eight weeks | ↓SBP, DBP, FBG, total cholesterol, and triglycerides in Tx1 ↑Paraoxonase-1 in Tx1 vs. Cx1 |
Schell et al. (2017)104 | Adults with T2D and WC > 89 cm (females) or >102 cm (males) on medications sample size: n = 25 | Randomized, crossover parallel-arm postprandial (4 h) study | High-fat fast-food-style breakfast (70 g fat, 974 kcal) with dried cranberries 40 g (Tx1) or banana 80 g (Cx1) | ↓2-Hour and 4-hour glucose in Tx1 |
Yang et al. (2017)85 | Adults with prediabetes or early untreated T2D sample size: n = 138 | Randomized, double-blind, placebo-controlled, parallel-arm study | Anthocyanin capsules (bilberry & black currant) 320 mg day−1 (Tx1); or placebo-capsule (Cx1) for 12 weeks | ↓HbA1C, LCL-c, apo A1, apo B in Tx1 vs. Cx1 |
Cai et al. (2015)89 | Adults with T2D on medications sample size: n = 67 | Randomized, controlled, parallel-arm study | Goji berry capsule 300 mg day−1 (Tx1); or placebo capsule (Cx1) for 3 months | ↓BG and ↑OMTT insulinogenic index and HDLs in Tx1 |
Moazen et al. (2013)84 | Adults with T2D, nonsmokers, not on medications sample size: n = 36 | Randomized, double-blind, placebo-controlled study | Strawberries freeze-dried ∼500 g day−1 fresh-equivalent (Tx1); or flavor- and macronutrient-matched placebo powder (Cx1) for six weeks | ↓CRP, MDA from baseline in Tx1 ↓HbA1C and ↑total antioxidants with control in Tx1 |
Shidfar et al. (2012)82 | Adult males with T2D sample size: n = 58 | Randomized, double-blind, placebo-controlled, parallel-arm study | Cranberry juice drink 1 cup per day (Tx1); or placebo (Cx1) for 12 weeks | ↓BG and apolipoprotein B in Tx1 vs. Cx1 and baseline ↑Apolipoprotein A1 and paraoxonase-1 activity in Tx1 vs. Cx1 and baseline |
Wilson et al. (2010)81 | Adults with T2D on medications sample size: n = 13 | Randomized, single-crossover postprandial (2 h) study | Raw cranberry 55 g (Tx1); or sweetened dried cranberries 40 g (Tx2); or reduced-sugar dried cranberries 40 g (Tx3); or white bread 57 g (Tx4) | ↑BG elevation persistence in Tx4 vs. other Tx groups ↓ 60 min plasma insulin in Tx3 vs. Tx2 and Tx4 ↓Insulin AUC Tx1 and Tx3 vs. Tx2 and Tx4 |
Abbreviations: apo: apolipoprotein, AUC: area under the curve, BP: blood pressure, CRP: C-reactive protein, Cx: control group, DBP: diastolic blood pressure; DM: diabetes mellitus, FBG: fasting blood glucose; FDS: freeze-dried strawberries, HbA1C: glycated hemoglobin, HDL: high-density lipoprotein, hsTNF: high-sensitivity tumor necrosis factor, IL: interleukin, MDA: malondialdehyde, SBP: systolic blood pressure; Tx: treatment group, OMTT: oral metabolic tolerance test, WC: waist circumference.